Kumlin M et al. |
Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4, and histamine in asthmatics. |
1992 |
Am. Rev. Respir. Dis. |
pmid:1320824
|
Landolfi R et al. |
Increased thromboxane biosynthesis in patients with polycythemia vera: evidence for aspirin-suppressible platelet activation in vivo. |
1992 |
Blood |
pmid:1327286
|
Uyama O et al. |
Urinary 11-dehydro-thromboxane B2: a quantitative index of platelet activation in cerebral infarction. |
1992 |
Intern. Med. |
pmid:1392173
|
Tohgi H et al. |
Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin. |
1992 |
Stroke |
pmid:1412574
|
Tanaka S et al. |
High dose of inhaled fluticasone reduces high levels of urinary leukotriene E4 in the early morning in mild and moderate nocturnal asthma. |
2003 |
Chest |
pmid:14605047
|
Minuz P et al. |
Determinants of platelet activation in human essential hypertension. |
2004 |
Hypertension |
pmid:14656953
|
Böhm E et al. |
11-Dehydro-thromboxane B2, a stable thromboxane metabolite, is a full agonist of chemoattractant receptor-homologous molecule expressed on TH2 cells (CRTH2) in human eosinophils and basophils. |
2004 |
J. Biol. Chem. |
pmid:14668348
|
Katoh K |
Possible relevance of lipid peroxidation and thromboxane production to the initiation and/or evolution of microangiopathy in non-hyperlipidemic type 2 diabetes mellitus. |
1992 |
Diabetes Res. Clin. Pract. |
pmid:1478157
|
Bruno A et al. |
Serial urinary 11-dehydrothromboxane B2, aspirin dose, and vascular events in blacks after recent cerebral infarction. |
2004 |
Stroke |
pmid:14963281
|
Ikonomidis I et al. |
Reduction of daily life ischaemia by aspirin in patients with angina: underlying link between thromboxane A2 and macrophage colony stimulating factor. |
2004 |
Heart |
pmid:15020512
|